Abstract
A short-course radiation therapy regimen (5 × 5 Gy) delivered immediately prior to surgery and a conventionally fractionated chemoradiotherapy regimen with a 6–8-week interval prior to surgery are the most commonly used schedules of preoperative radiotherapy for resectable rectal cancer. These two schedules were compared in a small (N = 312) randomized trial. At a median follow-up of 4 years, the anterior resection rate, postoperative complication rate, late toxicity rate, and anorectal/sexual dysfunction rate did not differ between groups. Long-term oncological outcomes (including local control, overall and disease-free survival) were similar, despite more favorable postoperative pathologic findings in the chemoradiotherapy group (i.e., smaller tumors, lower stage of disease, higher rates of pathological complete response, and fewer patients with involved radial margins). The acute adverse radiation effects and compliance rates were better in the short-course radiation group. Other studies have suggested that a short-course preoperative radiation regimen with a 6–8–week interval to surgery is a valuable treatment option for elderly patients who are unfit for chemotherapy, including patients with unresectable rectal cancer where transabdominal surgery is mandated or patients with small tumors prior to full-thickness local excision.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and evaluation of late secondary effects. Dis Colon Rectum. 1993;36:564–572.
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740.
Braendengen M, Tveit KM, Berglund A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687–3694.
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–1123.
Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620–4625.
Rew DA, Wilson GD, Taylor I, Weaver PC. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg. 1991;78:60–66.
Suwinski R, Taylor JM, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1998;42:943–951.
Basha G, Landuyt W, Fowler J, et al. An experimental evaluation of three preoperative radiation regimens for resectable rectal cancer. Ann Surg Oncol. 2002;9:292–297.
Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 2002;52:6–13.
START Trialists’ Group, Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331–341.
Suwinski R, Wzietek I, Tarnawski R, et al. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:793–799.
Stockholm Colorectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer. 1990;66:49–55.
Martling AL, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92:896–902.
Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644–5650.
Marijnen CA, Nagtegaal ID, Kapiteijn E, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003;55:1311–1320.
Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693–701.
Sebag-Montfiore D, Steele R, Quike P, et al. Short-course preoperative radiotherapy results improves outcome when compared with highly selective postoperative radiochemotherapy. Preliminary results of the MRC CR07 randomised trial. Radiother Oncol. 2006;81(suppl 1):s19 (abstract).
Bujko K, Richter P, Kolodziejczyk M, et al. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol. 2009;92(2):195–201.
Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20:817–825.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72:15–24.
Pahlman L, Glimelius B, Graffman S. Pre-versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomised multicentre trial. Br J Surg. 1985;72:961–966.
Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg. 1993;80:1333–1336.
Ngan S, Fisher R, Mackay J, et al. Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04). Eur J Cancer. 2007;5(suppl 4):237 (abstract).
Holm T, Rutqvist LE, Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg. 1996;83:964–968.
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987.
Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005;23:8697–8705.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg. 2008;95:206–213.
Peeters KCMJ, van de Velde CJ, Leer JWH, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients – a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199–6206.
Marijnen CAM, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of multicenter randomized trial. J Clin Oncol. 2005;23:1847–1858.
Frykholm JG, Sintorn K, Montelius A, Jung B, Pahlman S, Glimelius B. Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. Radiother Oncol. 1996;38:121–130.
Holm T, Singnomklao T, Rutqvist LE, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up in two randomised trials. Cancer. 1996;78:968–976.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomised trial comparing preoperative short-course radiotherapy vs. preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–1223.
Bujko K, Kepka L, Michalski W, Nowacki MP. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol. 2006;80:4–12.
Wong RKS, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev. 2007;(2):CD002102.
Bujko K, Nowacki MP, Kepka L, Oledzki J, Bębenek M, Kryj M. Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis. 2005;7:410–416.
Francois Y, Nemoz CJ, Bauliex J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396–2402.
Suit HD, Gallager HS. Intact tumor cells in irradiated tissue. Arch Pathol. 1964;78:648–651.
Pietrzak L, Bujko K, Nowacki MP, et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol. 2007;84:217–225.
Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19:1976–1984.
Mercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.
Radu C, Berglund K, Pahlman L, Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer – a retrospective study. Radiother Oncol. 2008;87:343–349.
Sebag-Montfiore D, Hingorani M, Radhakrishna G, et al. Short-course pre-operative radiotherapy with elective delay prior to surgery, in frail and poor PS patients with unresectable rectal cancer. Radiother Oncol. 2008;88(2):S220 (abstr.).
Widder J, Herbst F, Scheithauer W. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer. Acta Oncol. 2005;44:921–923.
Rutten H, den Dulk M, Lemmens V, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer. 2007;43:2295–2300.
Greenberg JA, Shibata D, Herndon JE II, Steele GD Jr, Mayer R, Bleday R. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum. 2008;51:1185–1191.
Bujko K, Sopylo R, Kepka L. Local excision after radio(chemo)therapy for rectal cancer: is it safe? Clin Oncol (R Coll Radiol). 2007;19:693–700.
Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–694.
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet. 2001;358:1291–1304.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005;23:6126–6131.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press
About this chapter
Cite this chapter
Bujko, K., Bujko, M. (2010). Radiation Therapy: Short Versus Long Course. In: Czito, B., Willett, C. (eds) Rectal Cancer. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-567-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-567-5_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-566-8
Online ISBN: 978-1-60761-567-5
eBook Packages: MedicineMedicine (R0)